# Conocophillips: financial statements, quarterly

COP · NYSE · CIK 1163165 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cop.md) · [Financials](/companies/cop/financials.md) · [Filings](/companies/cop/filings.md) · [Insiders](/companies/cop/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cop/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [12.6](/filings/0001163165-24-000052.md) | [12.9 d](/filings/0001163165-26-000009.md) | [12.3](/filings/0001163165-25-000025.md) | [12.7](/filings/0001163165-25-000042.md) | [11.7](/filings/0001163165-25-000058.md) | [12.7 d](/filings/0001163165-26-000009.md) | [14.5](/filings/0001163165-26-000018.md) | [12.6](/filings/0001163165-26-000032.md) | [13.3](/filings/0001163165-25-000058.md) | [11.4 d](/filings/0001163165-26-000009.md) | [13.5](/filings/0001163165-26-000018.md) | [18.1](/filings/0001163165-26-000032.md) |
| Cost of revenue | $bn | [5.5](/filings/0001163165-24-000052.md) | [5.7 d](/filings/0001163165-26-000009.md) | [5.3](/filings/0001163165-25-000025.md) | [4.9](/filings/0001163165-25-000042.md) | [4.7](/filings/0001163165-25-000058.md) | [5.1 d](/filings/0001163165-26-000009.md) | [6.2](/filings/0001163165-26-000018.md) | [5.1](/filings/0001163165-26-000032.md) | [5.9](/filings/0001163165-25-000058.md) | [5.2 d](/filings/0001163165-26-000009.md) | [6.3](/filings/0001163165-26-000018.md) | [6.7](/filings/0001163165-26-000032.md) |
| Selling, general and administrative | $bn | [0.2](/filings/0001163165-24-000052.md) | [0.2 d](/filings/0001163165-26-000009.md) | [0.2](/filings/0001163165-25-000025.md) | [0.2](/filings/0001163165-25-000042.md) | [0.2](/filings/0001163165-25-000058.md) | [0.6 d](/filings/0001163165-26-000009.md) | [0.2](/filings/0001163165-26-000018.md) | [0.3](/filings/0001163165-26-000032.md) | [0.3](/filings/0001163165-25-000058.md) | [0.2 d](/filings/0001163165-26-000009.md) | [0.2](/filings/0001163165-26-000018.md) | [0.2](/filings/0001163165-26-000032.md) |
| Income tax | $bn | [1.3](/filings/0001163165-24-000052.md) | [1.3 d](/filings/0001163165-26-000009.md) | [1.3](/filings/0001163165-25-000025.md) | [1.3](/filings/0001163165-25-000042.md) | [1.2](/filings/0001163165-25-000058.md) | [0.7 d](/filings/0001163165-26-000009.md) | [1.6](/filings/0001163165-26-000018.md) | [1.0](/filings/0001163165-26-000032.md) | [1.2](/filings/0001163165-25-000058.md) | [0.8 d](/filings/0001163165-26-000009.md) | [1.2](/filings/0001163165-26-000018.md) | [2.2](/filings/0001163165-26-000032.md) |
| Net income | $bn | [2.8](/filings/0001163165-24-000052.md) | [3.0 d](/filings/0001163165-26-000009.md) | [2.6](/filings/0001163165-25-000025.md) | [2.3](/filings/0001163165-25-000042.md) | [2.1](/filings/0001163165-25-000058.md) | [2.3 d](/filings/0001163165-26-000009.md) | [2.8](/filings/0001163165-26-000018.md) | [2.0](/filings/0001163165-26-000032.md) | [1.7](/filings/0001163165-25-000058.md) | [1.4 d](/filings/0001163165-26-000009.md) | [2.2](/filings/0001163165-26-000018.md) | [3.9](/filings/0001163165-26-000032.md) |
| Diluted EPS | $ per share | [2.32](/filings/0001163165-24-000052.md) | not reported | [2.15](/filings/0001163165-25-000025.md) | [1.98](/filings/0001163165-25-000042.md) | [1.76](/filings/0001163165-25-000058.md) | not reported | [2.23](/filings/0001163165-26-000018.md) | [1.56](/filings/0001163165-26-000032.md) | [1.38](/filings/0001163165-25-000058.md) | not reported | [1.78](/filings/0001163165-26-000018.md) | [3.23](/filings/0001163165-26-000032.md) |
| Basic EPS | $ per share | [2.33](/filings/0001163165-24-000052.md) | not reported | [2.16](/filings/0001163165-25-000025.md) | [1.99](/filings/0001163165-25-000042.md) | [1.77](/filings/0001163165-25-000058.md) | not reported | [2.23](/filings/0001163165-26-000018.md) | [1.56](/filings/0001163165-26-000032.md) | [1.38](/filings/0001163165-25-000058.md) | not reported | [1.78](/filings/0001163165-26-000018.md) | [3.23](/filings/0001163165-26-000032.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [8.8](/filings/0001163165-23-000031.md) | [5.6](/filings/0001163165-25-000012.md) | [5.6](/filings/0001163165-24-000023.md) | [4.3](/filings/0001163165-24-000037.md) | [5.2](/filings/0001163165-24-000052.md) | [5.6](/filings/0001163165-26-000009.md) | [6.3](/filings/0001163165-25-000025.md) | [4.9](/filings/0001163165-25-000042.md) | [5.3](/filings/0001163165-25-000058.md) | [6.5](/filings/0001163165-26-000032.md) | [5.9](/filings/0001163165-26-000018.md) | [6.6](/filings/0001163165-26-000032.md) |
| Current assets | $bn | [17.2](/filings/0001163165-23-000031.md) | [14.3](/filings/0001163165-25-000012.md) | [13.7](/filings/0001163165-24-000023.md) | [13.7](/filings/0001163165-24-000037.md) | [14.0](/filings/0001163165-24-000052.md) | [15.6](/filings/0001163165-26-000009.md) | [16.9](/filings/0001163165-25-000025.md) | [13.9](/filings/0001163165-25-000042.md) | [15.9](/filings/0001163165-25-000058.md) | [15.5](/filings/0001163165-26-000032.md) | [16.2](/filings/0001163165-26-000018.md) | [19.2](/filings/0001163165-26-000032.md) |
| Total assets | $bn | [93.7](/filings/0001163165-23-000031.md) | [95.9](/filings/0001163165-26-000009.md) | [95.3](/filings/0001163165-25-000025.md) | [96.0](/filings/0001163165-25-000042.md) | [96.7](/filings/0001163165-25-000058.md) | [123](/filings/0001163165-26-000009.md) | [124](/filings/0001163165-26-000018.md) | [123](/filings/0001163165-26-000032.md) | [122](/filings/0001163165-25-000058.md) | [122](/filings/0001163165-26-000032.md) | [123](/filings/0001163165-26-000018.md) | [124](/filings/0001163165-26-000032.md) |
| Current liabilities | $bn | [10.3](/filings/0001163165-23-000031.md) | [10.0](/filings/0001163165-25-000012.md) | [10.2](/filings/0001163165-24-000023.md) | [10.3](/filings/0001163165-24-000037.md) | [10.8](/filings/0001163165-24-000052.md) | [12.1](/filings/0001163165-26-000009.md) | [13.3](/filings/0001163165-25-000025.md) | [11.0](/filings/0001163165-25-000042.md) | [12.0](/filings/0001163165-25-000058.md) | [12.0](/filings/0001163165-26-000032.md) | [12.6](/filings/0001163165-26-000018.md) | [12.5](/filings/0001163165-26-000032.md) |
| Total liabilities | $bn | [45.9](/filings/0001163165-23-000031.md) | [46.6](/filings/0001163165-25-000012.md) | [46.0](/filings/0001163165-24-000023.md) | [46.2](/filings/0001163165-24-000037.md) | [46.8](/filings/0001163165-24-000052.md) | [58.0](/filings/0001163165-26-000009.md) | [59.0](/filings/0001163165-25-000025.md) | [57.0](/filings/0001163165-25-000042.md) | [57.5](/filings/0001163165-25-000058.md) | [57.5](/filings/0001163165-26-000032.md) | [58.2](/filings/0001163165-26-000018.md) | [58.9](/filings/0001163165-26-000032.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.9](/filings/0001163165-23-000031.md) | [1.1](/filings/0001163165-25-000012.md) | [1.1](/filings/0001163165-24-000023.md) | [1.3](/filings/0001163165-24-000037.md) | [1.3](/filings/0001163165-24-000052.md) | [1.0](/filings/0001163165-26-000009.md) | [0.6](/filings/0001163165-25-000025.md) | [0.4](/filings/0001163165-25-000042.md) | [1.0](/filings/0001163165-25-000058.md) | [1.0](/filings/0001163165-26-000032.md) | [1.1](/filings/0001163165-26-000018.md) | [0.5](/filings/0001163165-26-000032.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [47.7](/filings/0001163165-24-000052.md) | [49.3](/filings/0001163165-26-000009.md) | [49.3](/filings/0001163165-25-000042.md) | [49.7](/filings/0001163165-25-000058.md) | [49.9](/filings/0001163165-25-000058.md) | [64.8](/filings/0001163165-26-000032.md) | [65.2](/filings/0001163165-26-000032.md) | [65.6](/filings/0001163165-26-000032.md) | [64.9](/filings/0001163165-25-000058.md) | [64.5](/filings/0001163165-26-000032.md) | [64.5](/filings/0001163165-26-000032.md) | [65.3](/filings/0001163165-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5,445 d](/filings/0001163165-24-000052.md) | [5,263 d](/filings/0001163165-26-000009.md) | [4,985](/filings/0001163165-25-000025.md) | [4,919 d](/filings/0001163165-25-000042.md) | [5,763 d](/filings/0001163165-25-000058.md) | [4,457 d](/filings/0001163165-26-000009.md) | [6,115](/filings/0001163165-26-000018.md) | [3,485 d](/filings/0001163165-26-000032.md) | [5,878 d](/filings/0001163165-25-000058.md) | [4,318 d](/filings/0001163165-26-000009.md) | [4,295](/filings/0001163165-26-000018.md) | [7,434 d](/filings/0001163165-26-000032.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [1,337 d](/filings/0001163165-24-000052.md) | [1,408 d](/filings/0001163165-26-000009.md) | [924](/filings/0001163165-25-000025.md) | [915 d](/filings/0001163165-25-000042.md) | [910 d](/filings/0001163165-25-000058.md) | [897 d](/filings/0001163165-26-000009.md) | [998](/filings/0001163165-26-000018.md) | [984 d](/filings/0001163165-26-000032.md) | [975 d](/filings/0001163165-25-000058.md) | [1,038 d](/filings/0001163165-26-000009.md) | [1,032](/filings/0001163165-26-000018.md) | [1,025 d](/filings/0001163165-26-000032.md) |
| Share repurchases | $m | [1,300 d](/filings/0001163165-24-000052.md) | [1,100 d](/filings/0001163165-26-000009.md) | [1,325](/filings/0001163165-25-000025.md) | [1,021 d](/filings/0001163165-25-000042.md) | [1,167 d](/filings/0001163165-25-000058.md) | [1,950 d](/filings/0001163165-26-000009.md) | [1,500](/filings/0001163165-26-000018.md) | [1,222 d](/filings/0001163165-26-000032.md) | [1,274 d](/filings/0001163165-25-000058.md) | [1,022 d](/filings/0001163165-26-000009.md) | [1,006](/filings/0001163165-26-000018.md) | [2,000 d](/filings/0001163165-26-000032.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,269](/filings/0001163165-23-000031.md) | [1,223](/filings/0001163165-24-000023.md) | [1,210](/filings/0001163165-24-000037.md) | [1,200](/filings/0001163165-24-000052.md) | [1,180](/filings/0001163165-25-000025.md) | [1,170](/filings/0001163165-25-000042.md) | [1,163](/filings/0001163165-25-000058.md) | [1,275](/filings/0001163165-26-000018.md) | [1,259](/filings/0001163165-26-000032.md) | [1,247](/filings/0001163165-25-000058.md) | [1,225](/filings/0001163165-26-000018.md) | [1,214](/filings/0001163165-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,201,337,479 at 2026-06-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001163165-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.